Healthcare > Gene therapy for deafness

Tracking since May 19, 2026 · Latest signal May 6, 2026 · 9 matched data points

Overall sentiment

Positive 78% (7)Negative 0% (0)Neutral 22% (2)

Daily sentiment

Claims (2)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

The FDA has approved the first gene therapy for deafness, marking a significant advancement in treating genetic hearing loss.

Parent: HealthcareEntity: Gene therapy for deafnessImpact: positiveDate: Apr 23, 2026 - Apr 24, 2026Target: The approval of the first gene therapy for deafness by the FDA5 matched entries3 confirmed0 disputed2 neutral0 unclear

A new gene therapy has successfully restored hearing in some deaf children.

Parent: HealthcareEntity: Gene therapy for deafnessImpact: positiveDate: May 2, 2026 - May 6, 2026Target: A new gene therapy has successfully restored hearing in some deaf children.4 matched entries4 confirmed0 disputed0 neutral0 unclear